RCMI Coordinating Center (RCMI CC) Header Logo

Connection

Karam F. Soliman to Protein Kinase Inhibitors

Back to Details
This is a "connection" page, showing publications Karam F. Soliman has written about Protein Kinase Inhibitors.
Karam F. Soliman
Connection Strength
0.193
Protein Kinase Inhibitors
  1. Messeha SS, Nezami MA, Hager S, Soliman KFA. A Rare Presentation of a Non-Asian Female With Metastatic Non-small-cell Lung Cancer Harboring EGFR L747P Mutation With Clinical Response to Multi-targeted Epigenetic and EGFR Inhibition. Anticancer Res. 2022 Jan; 42(1):441-447.
    View in: PubMed
    Score: 0.193
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support